WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012127500) COMPOSITION FOR SPERMATOGENESIS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/127500    International Application No.:    PCT/IN2012/000165
Publication Date: 27.09.2012 International Filing Date: 12.03.2012
IPC:
A61K 8/24 (2006.01)
Applicants: SANZYME LIMITED [IN/IN]; A-2, Silver Belle, Srinivas Bagadkar Marg J.B. Nagar, Andheri (East) Mumbai 400059 Maharashtra (IN) (For All Designated States Except US).
PRASAD, K., V., S. [IN/IN]; (IN) (For US Only).
SOMAN, Jay, L. [IN/IN]; (IN) (For US Only)
Inventors: PRASAD, K., V., S.; (IN).
SOMAN, Jay, L.; (IN)
Agent: GOPAKUMAR, Nair, G.; Gopokumar Nair Associates 3rd Floor 'Shivmangal', Near Big Bazar Akurli Road, Kandival (East) Mumbai 400101 Maharashtra (IN)
Priority Data:
692/MUM/2011 11.03.2011 IN
Title (EN) COMPOSITION FOR SPERMATOGENESIS
(FR) COMPOSITION POUR LA SPERMATOGENÈSE
Abstract: front page image
(EN)The present invention is provides compositions comprising combination of gonadotropins for promoting spermatogenesis in males. Particularly the present invention provides a composition comprising a mixture of gonadotropins selected from but not limited to group consisting of Follicle-stimulating hormone (FSH), luteinizing hormone (LH) and Human chorionic gonadotropin (hCG), and pharmaceutical formulations comprising the same.
(FR)La présente invention concerne des compositions comprenant une combinaison de gonadotrophines pour promouvoir la spermatogenèse chez les hommes. L'invention concerne en particulier une composition comprenant un mélange de gonadotrophines choisies, de façon non limitative, dans le groupe comprenant l'hormone folliculostimulante (FSH), l'hormone lutéinisante (LH) et la gonadotrophine chorionique humaine (hCG), ainsi que des formulations pharmaceutiques comprenant cette composition.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)